GLG News by Obstetricians/Gynecologists
Articles with lock require a subscription to GLG News |
Request a free trial
January 18, 2007Health Middlemen! savior or curse?
Analysis of: As Health Middlemen Thrive, Employers Try to Tame Them | online.wsj.com
Author: John Spurlock, Medical Director, Continence Management Institute of the LeHigh Valley
1. Health middlemen drive up costs of healthcare2. Larger companies can probably do without the middleman3. Middlemen are probably necessary for most firms
January 17, 2007portable device will help to screen for counterfeit drugs
Analysis of: Portable drug anti-counterfeiting device to hit market | www.in-pharmatechnologist.com
Author: John Spurlock, Medical Director, Continence Management Institute of the LeHigh Valley
1. Portable device will be used by multiple industries2. Device should help to combat a growing problem3. $75 billion in counterfeit drugs
October 30, 2006HPV continues to rear its ugly head
Analysis of: Infection Cuts Pregnancy Rates With In-Vitro Fertilization | www.medscape.com
Author: John Spurlock, Medical Director, Continence Management Institute of the LeHigh Valley
1. Most women of reproductive age have HPV; therefore, most women undergoing invitro fertilization have HPV.2. I do not believe in vitro rates will decrease.3. News should boost Gardasil use!4. Should boost rates of In Vitro
October 23, 2006HPV DNA testing from Digene will replace pap smear
Analysis of: HPV DNA Testing Likely to Become Primary Cervical Cancer Screening Tool as Vaccine Use Expands, Predict International Experts | www.medicalnewstoday.com
Author: John Spurlock, Medical Director, Continence Management Institute of the LeHigh Valley
1. Digene should corner the market for HPV testing.2. HPV testing will become mandatory with introduction of HPV vaccines.3. Mutations should not be a problem for Digene.
October 19, 2006CollaGUARD is great addition in the foild of wound care
Analysis of: Innocoll's collagen wound care product approved by FDA | www.pipelinereview.com
Author: John Spurlock, Medical Director, Continence Management Institute of the LeHigh Valley
1.CollaGUARD should be a significant improvement over existing products for wound care.2.CollaGUARD is a profitable addition to the billion dollar wound care market.3.CollaGUARD may be superior to Regranex.
October 19, 2006Hemsley Should Clean House
Analysis of: McGuire is out at UnitedHealth: Hemsley in as CEO, board shuffled after options timing probe | www.chicagotribune.com
Author: John Spurlock, Medical Director, Continence Management Institute of the LeHigh Valley
1. New CEO Hemsley should improve UnitedHealth's profits2. The exit of McGuire should be good for UnitedHealth
October 19, 2006Arixtra is first in its class!
Analysis of: Fondaparinux Sodium Granted Priority Review | www.ptcommunity.com
Author: John Spurlock, Medical Director, Continence Management Institute of the LeHigh Valley
1. Fondaparinux Sodium is a new class of agents in the war against thrombosis.
2. Fondaparinux Sodium should achieve significant sales in the short term.
3. Fondaparinux Sodium is possibly superior to present agents, such as Plavix
October 19, 2006Ozarelix should change treatment of BPH
Analysis of: Æterna Zentaris Announces Positive Phase 2 Results for Ozarelix in Benign Prostatic Hyperplasia | www.pipelinereview.com
Author: John Spurlock, Medical Director, Continence Management Institute of the LeHigh Valley
1. Ozarelix is a revolutionary new medication for the treatment of benign prostatic hypertrophy.2. Ozarelix should replace current formulary medications for BPH3. Ozarelix is a significant improvement over GNRH agonists which have significant side effects.
Previous Page : 1 2 3 431 to 38 of 38
More GLG News in
Healthcare
Most Popular:
Source Article | Expert Analyses
Why the doctor can't see you now
seattlepi.nwsource.com
Johnson & Johnson buys medical device maker
www.nytimes.com
Potassium loss from blood pressure drugs may explain higher risk of adult diabetes
www.fiercebiotech.com
McKesson Agrees To Settlement In Pricing Suits
online.wsj.com
Use of Antipsychotics in Children Poses Risks of Adverse Effects
November 26, 2008
Avastin and clots? News to me. Black box warning? Why?
November 24, 2008
Off Label Use Can Be Prevented
November 24, 2008
Gardasil will most certainly be approved for boys
November 24, 2008
Medivations's (MDVN) Dimebon - We've Seen This Movie Before
November 24, 2008